Immediate Impact

68 standout
Sub-graph 1 of 22

Citing Papers

AXL signaling in cancer: from molecular insights to targeted therapies
2025 Standout
Energy metabolism in health and diseases
2025 Standout
3 intermediate papers

Works of Zongru Jiang being referenced

Pharmacologically inhibiting phosphoglycerate kinase 1 for glioma with NG52
2020
Discovery of 4-((N-(2-(dimethylamino)ethyl)acrylamido)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide (CHMFL-PDGFR-159) as a highly selective type II PDGFRα kinase inhibitor for PDGFRα driving chronic eosinophilic leukemia
2018

Author Peers

Author Last Decade Papers Cites
Zongru Jiang 158 15 26 48 40 19 262
Gabriela Mustata Wilson 153 5 8 48 51 21 310
Carlos Saus 149 2 15 66 32 15 298
Wojciech Senkowski 180 21 11 94 75 14 321
Jae Hoo Park 145 60 19 80 29 20 282
Waraporn Chan-on 106 2 5 60 75 14 233
Penghui Jia 160 2 7 62 29 21 319
Nicole Pinto 142 4 10 93 54 20 256
Ezanee Azlina Mohamad Hanif 165 1 10 48 87 18 265
H. Goldie 78 10 8 70 49 31 300
Kristin Paulsen Rye 103 166 47 61 29 17 316

All Works

Loading papers...

Rankless by CCL
2026